Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair

NCT00139152 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Lung Disease

Interventions

DRUG: Placebo
DRUG: Xolair

Sponsor

Creighton University

Collaborators

[object Object]